Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine Versus Idelalisib in Participants With Relapsed or Refractory Follicular Lymphoma
Clinical trial NCT04699461 · TERMINATED
Trial details
- NCT number
- NCT04699461
- Sponsor
- ADC Therapeutics S.A.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-04
- Primary completion
- 2022-11-25
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.